I ntraventrIcular hemorrhage (IVH) from germinal matrix hemorrhage is a frequent and problematic consequence of premature delivery. Historic rates of hemorrhage have ranged from 15% to 39% of preterm births in neonates weighing less than 1.5 kg.
control head growth and to treat the hydrocephalus. The VAD is used until the premature infant demonstrates a need for a permanent ventriculoperitoneal (VP) shunt and is large enough to tolerate the placement procedure.
Infections of VADs are common, and the prevalence has been reported in the literature at rates from approximately 5%-39%, with most studies reporting an approximate 5%-15% rate of infection. 1, 2, 7, 9 Infections of VADs can delay permanent shunt implantation and decrease the functional outcome in these infants. One study that examined preoperative antibiotic use found that VAD infection rates decreased 20% with the introduction of preoperative antibiotics. 2 Another study looking at serial taps of VADs found that additional taps do not necessarily correlate with increased infection rates. 5 A recent study by Kestle et al. 4 showed that the institution of a protocol for placement of VP shunts decreased infection rates from 8.8% to 5.7% (p = 0.0028) across multiple institutions. In this study, we hypothesized that the implementation of a shunt insertion protocol at our institution in 2007 would have a parallel effect of decreasing infections with other ventricular implants such as VADs as a result of institutional culture change.
methods study design
This was a single-center retrospective cohort study undertaken with the approval of the Primary Children's Hospital (PCH) Privacy Board and the University of Utah Institutional Review Board, with a waiver of consent. All data were obtained from PCH paper and electronic charts. Ten percent of charts were reviewed by 2 reviewers to ensure the accuracy of data abstraction.
study Population
Neonates in whom VADs were placed in the operating room during the period from June 1, 2003, to June 1, 2011, were identified. All VADs were preconnected by the manufacturer and none were impregnated with antibiotics. The cohort was assembled by interrogating the pediatric neurosurgical case database and cross-referencing with a billing database to ensure a consecutive sample of infants who underwent the insertion of a VAD at our institution. Preterm (less than 37 weeks gestation) infants with Grade III or IV IVH and PPHVD on imaging who underwent the implantation of a VAD, otherwise known as a ventricular reservoir, were included. Infants were excluded if they were temporized with a subgaleal shunt or died within 1 month of birth.
outcome variables
The primary outcome variable was infection of the VAD within 90 days of placement. All patient records were reviewed for 1 year after insertion to ensure detection of any delayed infections or complications. Infection was defined as a positive CSF culture sampled from the implant, a positive open implant wound culture, or exposed hardware. In all cases of confirmed infection, the VAD was surgically removed and serial lumbar punctures were used to control PPHVD until the infection was clinically cleared.
Additional variables in the analysis were gestational age (in weeks), birth weight (in grams), weight at procedure (in grams), gestational age (in weeks) at VAD insertion, postoperative hemorrhage as seen on imaging, death, surgeon, and 90-day infection outcome. In addition, patients with documented sepsis at any time during their hospitalizations, medical and surgical necrotizing enterocolitis (NEC) as documented by the neonatologists, and meningitis treated with antibiotics were also noted. All patients who had meningitis received a full course of antibiotics and had a negative CSF culture prior to VAD insertion.
Infections were also analyzed as they related to the implementation of a shunt insertion protocol at PCH. Prior 
statistical methods
Univariate results were expressed as counts and percentages for categorical variables and as means and SDs for continuous variables. The chi-square and Fisher exact tests were used for bivariate analyses for categorical variables, whereas t-tests were used for bivariate analyses for the continuous variables. The p values were reported for all of these analyses. Multivariate logistic regression was constructed to predict VAD infection by using significant bivariate factors as well as the variable of interest (era of infection protocol). Results from the final model were reported as p values and adjusted odds ratios with 95% confidence intervals. Statistical analyses were conducted using SAS (version 9.2).
results
A total of 105 patients were identified who met our criteria: 34 patients before 2006, 34 during 2006-2007, and 37 after June 1, 2007. Their average gestational age at birth (mean ± SD) was 27.9 ± 3.3 weeks, the mean gestational age at procedure was 31.9 ± 16.2 weeks, the mean birth weight was 1195 ± 497 g, and the mean weight at procedure was 1600 ± 559 g; 65% were male (Table 1) . A total of 12 infants had NEC (11.4%), of whom 7 (58%) required abdominal surgery. In our overall sample, 49% were treated for presumed sepsis during hospitalization, and 13.5% had a history of meningitis. There were 3 deaths and no new hemorrhages after placement. The use of IT antibiotics started at 0%, was 87.5% by 2007, and was 100% by 2009 (Fig. 1 ). This correlates with our time frame of preprotocol, implementation of protocol, and post-HCRN protocol ( Table 2) .
The overall infection rate was 11 of 105 (10.5%). Gestational age at procedure was a significant risk factor for VAD infection, with the average age of 26.4 weeks in the infected cohort compared with a mean age of 32.6 weeks for the noninfected group (p = 0.05). Meningitis was a significant risk factor for infection; 63% of the infected group had prior meningitis, whereas only 7% of the uninfected group had meningitis previously (p < 0.001). Meningitis was also significantly associated with death (p = 0.006). All the other variables were not significantly associated with VAD infection (Table 3) .
Infection rates by protocol era were as follows: 14.7% preprotocol, 11.8% during implementation, and 5.4% post-HCRN shunt infection protocol (p = 0.2). The absolute risk reduction was 9.3% in the preprotocol group compared with the postprotocol group, and the relative risk reduction was 63.3% (Table 4) .
When gestational age at procedure, a prior history of meningitis, and protocol era were analyzed using multivariate logistic regression, only a history of meningitis was independently associated with VAD infection (OR 21.5, 95% CI 5.0-91.7).
discussion
We present a retrospective cohort study of 105 neonates in whom VADs were placed for PPHVD. Eleven of these patients subsequently experienced a VAD infection, for an overall infection rate of 10.5%. Bivariate analyses showed that gestational age at procedure (p = 0.05) and meningitis (p < 0.001) were significant risk factors for VAD infection. In addition, meningitis was also significantly associated with death (p = 0.006).
Two previous studies have examined risk factors for infection in VADs and VP shunts in infants. The first, by Pople et al. 6 in 1992, found a VP shunt infection rate of 15.7% for infants less than 6 months old. This study found that age was the only major factor influencing the infection rate. A more recent study by Bruinsma et al. 2 found an infection rate of 33.3% in preterm infants with VADs or VP shunts. Of note, this study enrolled 39 preterm infants and is the largest study of infections associated with preterm infants with VADs/VP shunts in the literature. The authors concluded that prematurity and extremely low birth weight were significant factors contributing to VAD/ VP shunt infections. age as risk Factor Our study of 105 neonates is the largest series studying infection risk factors in preterm infants requiring neurosurgical intervention for CSF diversion. Like previous investigators, we found that age at the time of implantation was a risk factor for infection, with a significantly increased risk of infection in younger neonates (26 weeks vs 33 weeks, p = 0.05). 2, 6 We expected that younger age was significant because of the higher risk of comorbidities such as NEC and sepsis that comes with prematurity; however, our analyses demonstrated that these other risk factors were not significantly associated with VAD infection. Younger neonates are probably predisposed to infection because of a combination of a more fragile immune system and thinner skin overlying the protuberant hardware.
meningitis as risk Factor
A history of meningitis was also significantly associated with infection (p < 0.001) in both the bivariate and the multivariate analyses. It is interesting to note that meningitis was associated with infection, whereas NEC or presumed sepsis was not, because these conditions would also seem to be significant risk factors for VAD infections. The lack of other infection-related variables may be due to the relatively small sample size of infected infants; however, we did find that meningitis is a clear risk factor and that it may be worthwhile to defer VAD placement as long as possible in patients with meningitis. Conversely, it may be safer than previously thought to place VADs in infants with a recent history of NEC or other systemic infections.
New Protocol
While we were studying VAD infection, a standardized protocol was introduced to reduce shunt infection; therefore, we also considered whether our efforts to reduce shunt infection had any impact on VAD infection. In fact, we did observe fewer VAD infections during this time, although the difference was not significant (decrease from 14.7% to 5.4%, p = 0.2).
We found it interesting that the VAD infection rate seemed to decrease coincidentally with the introduction of the shunt infection protocol. Because culture change is an important component of quality improvement, it is possible that members of the operating room team may have changed their behavior as a result of their experiences with the shunt insertion protocol, and perhaps this contributed to the decreased infection rate. The only change in behavior during VAD operations that we could reliably identify in the medical record was IT antibiotic use, which increased from 0% to 87.5% to 100%. Although antibiotic use alone did not impact infection rates in shunt surgery, 4 it does appear to indicate a change in behavior during VAD procedures. This leads us to believe that a standard protocol for shunt surgery highlighted the infection issue and emphasized infection prevention, and may have contributed to reduced infections.
limitations of the study
The main limitation of this study is that it is a retrospective cohort study and not a prospective trial. Another significant limitation is that there were only 11 infections (outcomes) in this cohort, decreasing the power of this study. In this retrospective review, we were not able to assess operating room team behaviors accurately, and therefore our suggestion that the team's behavior changed as a result of the infection protocol is only a hypothesis. Nevertheless, we believe that the trends seen in this study warrant further multicenter prospective studies.
conclusions
Neonates with PPHVD are at high risk for infection. Our study found that gestational age (less than 26 weeks) and a recent history of meningitis were statistically significant risk factors for VAD infection. In addition, we found that the implementation of a shunt insertion protocol at the institution may have had a clinical effect on the reduction of infections in this other patient population because of a change in the operating room culture that led to greater attention to infection prevention. We recommend a further multiinstitutional study on the effect of a protocol to decrease VAD infections in the premature infant population.
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